Changes in the levels of anti-phospholipase A2 and hyaluronidase antibodies during bee venom immunotherapy.
D000818:Animals; D001514:Bee Venoms / Q000008:administration & dosage* / Q000276:immunology; D001516:Bees; D001667:Binding, Competitive; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000276:immunology; D007073:Immunoglobulin E / Q000096:biosynthesis; D007074:Immunoglobulin G / Q000096:biosynthesis*; D007299:Insect Bites and Stings / Q000276:immunology / Q000628:therapy*; D010741:Phospholipases A / Q000276:immunology
D001514:Bee Venoms; D007074:Immunoglobulin G; D007073:Immunoglobulin E; D010741:Phospholipases A; D006821:Hyaluronoglucosaminidase